Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
J&J to Buy Heart-Pump Maker Abiomed for $17.3 Billion.
In: Bloomberg.com, 2022-11-01, S. N.PAG
Online
serialPeriodical
Zugriff:
J&J Outlook The Abiomed purchase is the first big deal for J&J's Joaquin Duato, who took over as the company's CEO in January. Duato said that the deal between the two companies will "complement Abiomed's capabilities" and move J&J into higher-growth markets, while accelerating near and long term sales and earnings growth. [Extracted from the article]
Titel: |
J&J to Buy Heart-Pump Maker Abiomed for $17.3 Billion.
|
---|---|
Autor/in / Beteiligte Person: | Muller, Madison |
Zeitschrift: | Bloomberg.com, 2022-11-01, S. N.PAG |
Veröffentlichung: | 2022 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|